ocal anaesthesia for transperineal prostate biopsy – a randomised control trial

Phase 2

Recruiting

• Conditions: Prostate biopsy; Cancer - Prostate; Anaesthesiology - Pain management

• Registration Number: ACTRN12616001310459
• Lead Sponsor: Professor Damien Bolton

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 155

Inclusion Criteria

Men who are undergoing transperineal prostate biopsy will be included in this study

Exclusion Criteria

Participants will be considered ineligible if there is a contraindication to infiltration of local anaesthetic (e.g. allergy or previous adverse drug reaction) or they are unable to give informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Postoperative pain assessed via VAS and Short McGill Pain Questionnaires[Primary timepoint: Pain questionnaire to be filled out 30 minutes post procedure in the recovery bay]

Secondary Outcome Measures

Name	Time	Method
Complications post procedure such as urinary retention, re-admission, post-operative infection (perineum or prostate). These outcomes will be assessed via review of patient medical records[Within 30 days of procedure]